SCHEMBL20109308

SCHEMBL20109308

CN1c2ccccc2N(C)P1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.37
GAA P10253 4/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
PAX8 Q06710 1/20 0.34
MCL1 Q07820 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TTR P02766 1/20 0.33
CES1 P23141 1/20 0.33
KDM4E B2RXH2 3/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 2/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
GPR3 P46089 2/20 0.31
ADRA2C P18825 1/20 0.31
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109310 0.67 FAAH (0.31)
SCHEMBL13636983 0.65
SCHEMBL482716 0.65 MAOA (0.60) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL29390564 0.65 MAOA (0.60) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL4571020 0.65 MAOA (0.60) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL20109312 0.63 GAA (0.33) GAAALDH1A1L3MBTL1CES1KDM4E
SCHEMBL29151795 0.63 MAOA (0.43) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL30705335 0.63 MAOA (0.43) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL1412726 0.61 PDGFRB (0.42) MAOAGAAALDH1A1LMNAPAX8
SCHEMBL20955684 0.61 LMNA (0.50) MAOAGAAALDH1A1LMNAPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MAOA 3698/4885GAA 4181/4885ALDH1A1 4621/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 MAOA 3698/4885GAA 4181/4885ALDH1A1 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.